KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Inventory Average (2016 - 2024)

Historic Inventory Average for Nektar Therapeutics (NKTR) over the last 14 years, with Q2 2024 value amounting to $15.4 million.

  • Nektar Therapeutics' Inventory Average fell 2497.56% to $15.4 million in Q2 2024 from the same period last year, while for Jun 2024 it was $15.4 million, marking a year-over-year decrease of 2497.56%. This contributed to the annual value of $17.7 million for FY2023, which is 85.71% up from last year.
  • Latest data reveals that Nektar Therapeutics reported Inventory Average of $15.4 million as of Q2 2024, which was down 2497.56% from $16.2 million recorded in Q1 2024.
  • In the past 5 years, Nektar Therapeutics' Inventory Average ranged from a high of $20.5 million in Q2 2023 and a low of $12.7 million during Q3 2020
  • For the 5-year period, Nektar Therapeutics' Inventory Average averaged around $16.1 million, with its median value being $15.7 million (2021).
  • As far as peak fluctuations go, Nektar Therapeutics' Inventory Average surged by 2651.17% in 2023, and later plummeted by 2497.56% in 2024.
  • Quarter analysis of 5 years shows Nektar Therapeutics' Inventory Average stood at $14.1 million in 2020, then grew by 10.46% to $15.6 million in 2021, then grew by 22.9% to $19.1 million in 2022, then decreased by 18.37% to $15.6 million in 2023, then dropped by 1.69% to $15.4 million in 2024.
  • Its Inventory Average stands at $15.4 million for Q2 2024, versus $16.2 million for Q1 2024 and $15.6 million for Q4 2023.